Posted by Michael Wonder on 19 Jun 2017
The amount you pay for cancer drugs may double -- here's why
19 June 2017 - Cancer immunotherapies could push the price patients and insurers pay for cancer drugs through the roof.
Chances are that you need little or no reminder about how expensive prescription drug costs are these days. If you've been to the pharmacy at any point over the past couple of years, you know!
According to findings from AARP, the aggregate cost of branded, specialty, and generic drugs rose more than 170% for older Americans between 2005 and 2013. However, drug price hikes have been particularly noticeable for specialty drugs, especially cancer drugs. Per the IMS Institute for Healthcare Informatics' annual Global Oncology Trend Report, cancer drug sales could balloon to $150 billion by 2020 from just $107 billion in 2015.
